Skip to content

Caudal Block for Inguinal Hernioplasty in Children

Efficacy and Safety of General Anesthesia With Caudal Block for Inguinal Hernioplasty in Children: a Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05958589
Enrollment
70
Registered
2023-07-24
Start date
2022-01-08
Completion date
2024-07-20
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

general anesthesia, caudal block, pain, hemodynamic parameters

Brief summary

This is a prospective, randomized, controlled clinical study designed to determine the effectiveness of caudal block combined with general anesthesia in providing intra- and postoperative analgesia, and its effect on hemodynamic stability and drug consumption.

Detailed description

This prospective, randomized, controlled clinical study will include 70 boys aged 3-5 years scheduled for inguinal herniorrhaphy. Participants will be randomized in 1:1 ratio into two groups. The first group will receive general anesthesia for surgery, while the second group will receive general anesthesia in combination with caudal block. Postoperative pain, hemodynamic parameters and total consumption of all medicaments in the perioperative period will be monitored. Complications and side effects of drugs will be observed as well.

Interventions

DRUGCaudal block with levobupivacaine

After the introduction of general anesthesia, a single shot caudal block will be performed with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg).

DRUGGeneral anesthesia

On the day of operation all patients will recieve midazolam 0.5 mg/kg (maximum dose 15 mg) orally. Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg). The airway will be obtained by placing a laryngeal mask (I-gel®).

Elective inguinal hernioplasty

Sponsors

University of Novi Sad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
3 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* boys between 3 to 5 years old * scheduled for elective inguinal hernioplasty * without comorbidities and chronic therapy, ASA class I * body mass and growth normal for the given age * no allergies * no congenital anomalies and birth complications

Exclusion criteria

* emergency surgeries * surgeries longer than 60 minutes * acute infections with leucocytosis/leucopenia * acute or chronic diseases * deformities and disorders of spine and nervous system * allergies * pilonidal cyst and/or inflammation in sacral region

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain5 hoursPostoperative pain level measured using the visual analog scale (VAS)

Secondary

MeasureTime frameDescription
Blood pressure5 hoursNoninvasive measurement of systolic and diastolic blood pressure
Heart rate5 hoursHeart rate measured with electrocardiogram

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026